APA (7th ed.) Citation

E, J., T, S., C, R., D, N., A, D., RS, F., . . . Z, S. (2025). Cytomegalovirus reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma. Blood cancer journal, 15(1), 189. https://doi.org/10.1038/s41408-025-01393-8

Chicago Style (17th ed.) Citation

E, Jurgens, et al. "Cytomegalovirus Reactivation During Treatment with Bispecific Antibodies for Relapsed/refractory Multiple Myeloma." Blood Cancer Journal 15, no. 1 (2025): 189. https://doi.org/10.1038/s41408-025-01393-8.

MLA (9th ed.) Citation

E, Jurgens, et al. "Cytomegalovirus Reactivation During Treatment with Bispecific Antibodies for Relapsed/refractory Multiple Myeloma." Blood Cancer Journal, vol. 15, no. 1, 2025, p. 189, https://doi.org/10.1038/s41408-025-01393-8.